1.A Case of Acute Pancreatitis Induced by Multiple Drugs in a Patient with Ulcerative Colitis.
Chang Nam SON ; Hang Lak LEE ; Yong Won JOO ; Oh Young LEE ; Dong Soo HAN ; Byung Chul YOON ; Ho Soon CHOI ; Joon Soo HAHM
The Korean Journal of Gastroenterology 2008;52(3):192-195
Acute pancreatitis is a serious disease with fatality rate up to 15%. We recently experienced a case of acute pancreatitis induced by multiple drugs in a patient with ulcerative colitis. A 20-year-old female visited with abdominal pain and hematochezia and diagnosed of ulcerative colitis. Sulfasalazine and prednisolone were used. However, acute pancreatitis occurred after 4 weeks of treatment with additional azathioprine treatment. Drug-induced pancreatitis was suspected, and she was recovered with conventional therapy for acute pancreatitis. Therefore, it was proposed that acute pancreatitis was induced by azathioprine. However, after the administration of sulfasalazine, pancreatitis relapsed. Furthermore, even the re-administration of 5-ASA and azathioprine induced relapse of acute pancreatitis. We concluded that acute pancreatitis was induced by multiple drugs in this patient with ulcerative colitis.
Acute Disease
;
Anti-Inflammatory Agents, Non-Steroidal/adverse effects
;
Antimetabolites/adverse effects
;
Azathioprine/adverse effects
;
Colitis, Ulcerative/diagnosis/*drug therapy
;
Colonoscopy
;
Female
;
Humans
;
Mesalamine/adverse effects
;
Pancreatitis/*chemically induced/*diagnosis
;
Sulfasalazine/adverse effects
;
Tomography, X-Ray Computed
;
Young Adult
2.The Effects of Sulphasalazine on Urinary Excretion of the Hydroxypyridinium Crosslinks of Collagen in Patients with Rheumatoid Arthritis.
Keskin DILEK ; Inal ALI ; Goksal KESKIN ; Tutkak HUSEYIN ; Tokgoz GUNER
Yonsei Medical Journal 2002;43(4):435-440
Secondary osteoporosis is a feature of rheumatoid arthritis (RA). In recent years, several attempts have been made to develop specific markers for monitoring connective tissue metabolism in arthritic diseases. Our purpose, in this study was to assess pyridinium crosslinks (PYD and DPYD) excretion in relation to the activity of RA (changes related to sulphasalazine treatment). Fourty premenopausal female patients with active RA (mean age; 36.0 7.2 years), 20 postmenopausal women with active RA (mean age; 60.0 6.8 years), 23 postmenopausal women with OA (mean age; 56.1 6.6 years) and 17 premenopausal healthy subjects (mean age; 28.3 4.28 years) were enrolled in our study. All of the 40 premenopausal female patients with active RA were given sulphasalazine. The mean follow up period for these patients was 10.3 1.1 months. In all of these patients, urine samples were collected both in the active and in the inactive periods. Urine PYD and DPYD levels were measured by ELISA. Urine PYD levels were significantly higher in the active period (14.01 3.16 nmol/mmol cr) than in the inactive (8.25 4.23 nmol/mmol cr) period in patients with premenopausal RA (p 0.05). Urine PYD levels were significantly high in postmenopausal active RA patients (19.06 3.26 nmol/mmol cr) compared to premenopausal active and ind inactive, postmenopausal inactive RA patients, osteoarthritis and healthy controls. Urine DPYD excretion was similar in patients with premenopausal RA in the active (7.46 2.13 nmol/mmol cr) and inactive periods (5.08 0.87 nmol/mmol cr) (p 0.05). In active premenopausal RA patients, a correlation was found between PYD excretion and RAI, ESR, CRP and functional capacity (r=0.5729 p 0.01, r=0.5953 p 0.01, r=0.6125 p 0.01 and r=0.6232, p 0.01 respectively). But in the inactive period, no such correlation was was evident. In disease activity parameters did not correlate with DPYD excretion in either the active or the inactive period. As a result, urine PYD excretion was significantly high in patients with active RA. During sulphasalazine treatment, urine PYD levels decreased. This is attributed to improvement in bone destruction.
Adrenal Cortex Hormones/adverse effects
;
Adult
;
Aged
;
Amino Acids/*urine
;
Arthritis, Rheumatoid/*urine
;
Collagen/*urine
;
Female
;
Human
;
Middle Age
;
Osteoporosis/urine
;
Sulfasalazine/*pharmacology
3.Retrospective study of adverse events in patients with rheumatoid arthritis treated with second-line drugs.
Lindi JIANG ; Naiqing ZHAO ; Liqing NI
Chinese Journal of Epidemiology 2002;23(3):213-217
OBJECTIVETo evaluate rates on the adverse side effect and discontinuation of second-line drugs frequently used in the treatment of rheumatoid arthritis (RA).
METHODEight hundred and sixty-four RA patients were studied in a retrospective program.
RESULTSUpper abdominal discomfort was most commonly seen when using second-line drugs. Rash was often associated with D-penicillamine (20.6%) and Sinomenium therapy (13.7%). Methotrexate (MTX) was uniquely characterized by substantial upper GI toxicity (32.2%) and Tripterygium wilfordii Hook. f. (TWH) (14.4%) by menstrual abnormality. Sulfasalazine users reported adverse events including upper abdominal trouble (39.0%), nausea (7.3%) and anorexia (7.3%) while the risk of GI malaise was greater. Patients taking hydroxychloroquine complained of blurred vision (19.6%) but no one went blind. Toxic side effects seemed to be the most common reasons for stoppages, and the patients taking MTX had the lowest discontinuation rate. Combination of D-penicillamine and Methotrexate did not increase the incidence of adverse events.
CONCLUSIONSKnowledge on these different patterns of toxicity provided choices in the selection of second line agents for particular RA patients. However, long-term monitor are required when drugs are being used.
Adult ; Anorexia ; chemically induced ; Antirheumatic Agents ; adverse effects ; therapeutic use ; Arthritis, Rheumatoid ; drug therapy ; Exanthema ; chemically induced ; Female ; Gastrointestinal Diseases ; chemically induced ; Humans ; Hydroxychloroquine ; adverse effects ; therapeutic use ; Male ; Methotrexate ; adverse effects ; therapeutic use ; Middle Aged ; Nausea ; chemically induced ; Penicillamine ; adverse effects ; therapeutic use ; Phytotherapy ; Plant Preparations ; adverse effects ; therapeutic use ; Retrospective Studies ; Sinomenium ; Sulfasalazine ; adverse effects ; therapeutic use
4.Relapsing Course of Sulfasalazine-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Complicated by Alopecia Universalis and Vitiligo.
Bertrand Sy LIAN ; Inny BUSMANIS ; Haur Yueh LEE
Annals of the Academy of Medicine, Singapore 2018;47(11):492-493
Alopecia
;
chemically induced
;
diagnosis
;
Antirheumatic Agents
;
administration & dosage
;
adverse effects
;
Arthritis, Rheumatoid
;
drug therapy
;
Biopsy
;
methods
;
Cyclosporine
;
administration & dosage
;
Dermatologic Agents
;
administration & dosage
;
Drug Hypersensitivity Syndrome
;
diagnosis
;
etiology
;
physiopathology
;
therapy
;
Humans
;
Male
;
Middle Aged
;
Prednisolone
;
administration & dosage
;
Skin
;
pathology
;
Sulfasalazine
;
administration & dosage
;
adverse effects
;
Symptom Flare Up
;
Treatment Outcome
;
Vitiligo
;
chemically induced
;
diagnosis
5.Drug-induced lymphadenitis.
Wei-hua YIN ; Hong-yu ZHANG ; Xue-feng LI ; Ya MA
Chinese Journal of Pathology 2010;39(3):192-194
Adult
;
Anti-Inflammatory Agents, Non-Steroidal
;
adverse effects
;
therapeutic use
;
CD3 Complex
;
metabolism
;
Colitis, Ulcerative
;
drug therapy
;
Diagnosis, Differential
;
Drug Hypersensitivity
;
etiology
;
metabolism
;
pathology
;
Female
;
Gastrointestinal Agents
;
adverse effects
;
therapeutic use
;
Humans
;
Immunoblastic Lymphadenopathy
;
metabolism
;
pathology
;
Ki-1 Antigen
;
metabolism
;
Lymphadenitis
;
chemically induced
;
metabolism
;
pathology
;
Lymphoma, Large-Cell, Anaplastic
;
metabolism
;
pathology
;
Lymphoma, T-Cell
;
metabolism
;
pathology
;
Receptors, Complement 3d
;
metabolism
;
Sulfasalazine
;
adverse effects
;
therapeutic use